skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cell specific radiation dosimetry in skeleton from life-span carcinogenesis studies. Final report

Technical Report ·
DOI:https://doi.org/10.2172/10140091· OSTI ID:10140091

The osteogenic sarcoma is the dominant life-threatening pathology in lifespan studies of beagles exposed to alpha-emitting bone-seeking radionuclides. It was deduced from these studies that certain skeletal sites are more prone to develop tumors. This project sought to determine the bone cells at risk and their cell-specific radiation dose. The cell-specific radiation dose values are related to loss and high Ra-226 and Pu-239 induced osteogenic sarcoma sites, to test different dose response hypothesis and predict the extent of effects in humans.

Research Organization:
Utah Univ., Salt Lake City, UT (United States). Radiobiology Div.
Sponsoring Organization:
USDOE, Washington, DC (United States)
DOE Contract Number:
FG02-89ER60764
OSTI ID:
10140091
Report Number(s):
DOE/ER/60764-T1; ON: DE93011620
Resource Relation:
Other Information: PBD: 5 Apr 1993
Country of Publication:
United States
Language:
English